Exact Mass: 695.294161

Exact Mass Matches: 695.294161

Found 27 metabolites which its exact mass value is equals to given mass value 695.294161, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

RifamycinS

Rifamycin S

C37H45NO12 (695.294161)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins Rifamycin S, a quinone, is an antibiotic against Gram-positive bacteria (including MRSA). Rifamycin S is the oxidized forms of a reversible oxidation-reduction system involving two electrons. Rifamycin S generates reactive oxygen species (ROS) and inhibits microsomal lipid peroxidation. Rifamycin S can be used for tuberculosis and leprosy[1][2][3].

   

Elobixibat

2-[2-(2-{[3,3-dibutyl-7-(methylsulfanyl)-1,1-dioxo-5-phenyl-2,3,4,5-tetrahydro-1lambda6,5-benzothiazepin-8-yl]oxy}acetamido)-2-phenylacetamido]acetic acid

C36H45N3O7S2 (695.2698780000001)


   

Kynostatin 227

N-Tert-butyl-3-{2-hydroxy-3-[(1-hydroxy-2-{[1-hydroxy-2-(isoquinolin-5-yloxy)ethylidene]amino}-3-(methylsulphanyl)propylidene)amino]-4-phenylbutanoyl}-5,5-dimethyl-1,3-thiazolidine-4-carboximidic acid

C35H45N5O6S2 (695.281111)


   

Rifamycins

2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^{4,7}.0^{5,28}]triaconta-1,3,5(28),9,19,21,25-heptaen-13-yl acetate

C37H45NO12 (695.294161)


   

Z-Vdvad-fmk

2-({2-[(2-{[(benzyloxy)(hydroxy)methylidene]amino}-1-hydroxy-3-methylbutylidene)amino]-1-hydroxy-4-methoxy-4-oxobutylidene}amino)-N-{1-[(5-fluoro-1-methoxy-1,4-dioxopentan-3-yl)-C-hydroxycarbonimidoyl]ethyl}-3-methylbutanimidate

C32H46FN5O11 (695.3177698)


   

8-Deoxy-3-hydroxyrifamycin S

8-Deoxy-3-hydroxyrifamycin S

C37H45NO12 (695.294161)


   

MS000059919

MS000059919

C33H41N7O6S2 (695.2559606)


   

1alpha,6beta-diacetoxy-9beta-benzoyloxy-15(2)-methylbutyroyloxy-8alpha-nicotynoyloxy-4beta-hydroxy-dihydro-beta-agarofuran

1alpha,6beta-diacetoxy-9beta-benzoyloxy-15(2)-methylbutyroyloxy-8alpha-nicotynoyloxy-4beta-hydroxy-dihydro-beta-agarofuran

C37H45NO12 (695.294161)


   

GSK163929B

GSK163929B

C36H40ClF2N5O3S (695.2508304)


CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3265; ORIGINAL_PRECURSOR_SCAN_NO 3263 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3281; ORIGINAL_PRECURSOR_SCAN_NO 3278 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3261; ORIGINAL_PRECURSOR_SCAN_NO 3260 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3276; ORIGINAL_PRECURSOR_SCAN_NO 3273 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3269; ORIGINAL_PRECURSOR_SCAN_NO 3267 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3265; ORIGINAL_PRECURSOR_SCAN_NO 3262 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6838; ORIGINAL_PRECURSOR_SCAN_NO 6836 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6880; ORIGINAL_PRECURSOR_SCAN_NO 6878 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6873; ORIGINAL_PRECURSOR_SCAN_NO 6871 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6893; ORIGINAL_PRECURSOR_SCAN_NO 6892 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6899; ORIGINAL_PRECURSOR_SCAN_NO 6897 CONFIDENCE standard compound; INTERNAL_ID 658; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6903; ORIGINAL_PRECURSOR_SCAN_NO 6901

   

DIETHYL (4-{BIS-[4-(DIETHOXY-PHOSPHORYLMETHYL)-PHENYL]-AMINO}-BENZYL)-PHOSPHONATE

DIETHYL (4-{BIS-[4-(DIETHOXY-PHOSPHORYLMETHYL)-PHENYL]-AMINO}-BENZYL)-PHOSPHONATE

C33H48NO9P3 (695.2541788)


   

Elobixibat

Elobixibat

C36H45N3O7S2 (695.2698780000001)


C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation

   

Cbz-DL-Val-DL-Asp(OMe)-DL-Val-DL-Ala-DL-Asp(OMe)-CH2F

Cbz-DL-Val-DL-Asp(OMe)-DL-Val-DL-Ala-DL-Asp(OMe)-CH2F

C32H46FN5O11 (695.3177698)


Z-VDVAD-FMK is a special inhibitor of caspase-2. Z-VDVAD-FMK produces a reduction in Lovastatin-induced apoptosis[1][2][3].

   

N-acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine

N-acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine

C27H45N5O16 (695.286117)


D007155 - Immunologic Factors

   

Dtxcid4027311

Dtxcid4027311

C36H40ClF2N5O3S (695.2508304)


   

N-acetyl-(N-acetylglucosaminyl)muramoyl-L-alanyl-D-isoglutamine

N-acetyl-(N-acetylglucosaminyl)muramoyl-L-alanyl-D-isoglutamine

C27H45N5O16 (695.286117)


   

N-[[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-16-[(4-methoxyphenyl)sulfonylamino]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

N-[[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-16-[(4-methoxyphenyl)sulfonylamino]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C37H49N3O8S (695.3240194000001)


   

4-[2-[2-[3-Acetamido-5-[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoic acid

4-[2-[2-[3-Acetamido-5-[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoic acid

C27H45N5O16 (695.286117)


   

PC 20:5/7:3;O3

PC 20:5/7:3;O3

C35H54NO11P (695.3434304)


   

PC 27:8;O3

PC 27:8;O3

C35H54NO11P (695.3434304)


   

PE 22:5/8:3;O3

PE 22:5/8:3;O3

C35H54NO11P (695.3434304)


   

PE 22:6/8:2;O3

PE 22:6/8:2;O3

C35H54NO11P (695.3434304)


   

PE 30:8;O3

PE 30:8;O3

C35H54NO11P (695.3434304)


   

LNAPS 29:7;O

LNAPS 29:7;O

C35H54NO11P (695.3434304)


   

PS 20:5/8:3;O2

PS 20:5/8:3;O2

C34H50NO12P (695.307047)


   

PS 22:4/7:3;O

PS 22:4/7:3;O

C35H54NO11P (695.3434304)


   

PS 28:8;O2

PS 28:8;O2

C34H50NO12P (695.307047)


   

PS 29:7;O

PS 29:7;O

C35H54NO11P (695.3434304)